Article
Annexin A1 expression in a pooled breast cancer series: association with tumor subtypes and prognosis.
BMC medicine - 2 Jul 2015
Sobral-Leite Marcelo, Wesseling Jelle, Smit Vincent T H B M, Nevanlinna Heli, van Miltenburg Martine H, Sanders Joyce, Hofland Ingrid, Blows Fiona M, Coulson Penny, Patrycja Gazinska, Schellens Jan H M, Fagerholm Rainer, Heikkilä Päivi, Aittomäki Kristiina, Blomqvist Carl, Provenzano Elena, Ali Hamid Raza, Figueroa Jonine, Sherman Mark, Lissowska Jolanta, Mannermaa Arto, Kataja Vesa, Kosma Veli-Matti, Hartikainen Jaana M, Phillips Kelly-Anne, Couch Fergus J, Olson Janet E, Vachon Celine, Visscher Daniel, Brenner Hermann, Butterbach Katja, Arndt Volker, Holleczek Bernd, Hooning Maartje J, Hollestelle Antoinette, Martens John W M, van Deurzen Carolien H M, van de Water Bob, Broeks Annegien, Chang-Claude Jenny, Chenevix-Trench Georgia, Easton Douglas F, Pharoah Paul D P, García-Closas Montserrat, de Graauw Marjo, Schmidt Marjanka K
Abstract excerpt
BACKGROUND: Annexin A1 (ANXA1) is a protein related with the carcinogenesis process and metastasis formation in many tumors. However, little is known about the prognostic value of ANXA1 in breast cancer. The purpose of this study is to evaluate the association between ANXA1 expression, BRCA1/2 germline carriership, specific tumor subtypes and survival in breast cancer patients. METHODS: Clinical-pathological...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.